(Q31055937)

28 June 2017

1 reference

title

The use of accelerator mass spectrometry to obtain early human ADME/PK data (English)

1 reference

28 June 2017

Graham Lappin

1

1 reference

28 June 2017

R Colin Garner

series ordinal

2

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Expert Opinion on Drug Metabolism & Toxicology

28 June 2017

published in

1 reference

28 June 2017

volume

1

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

23-31

1 reference

Recent advances in the applications of radioisotopes in drug metabolism, toxicology and pharmacokinetics

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Current perspectives of 14 C-isotope measurement in biomedical accelerator mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

An interface for direct analysis of (14)c in nonvolatile samples by accelerator mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Stable isotopes in clinical pharmacokinetic investigations. Advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Pharmacokinetics of N-acetylprocainamide in patients profiled with a stable isotope method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Big physics, small doses: the use of AMS and PET in human microdosing of development drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

Direct dating of archaeological pottery by compound-specific 14C analysis of preserved lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.1.1.23

21 January 2018

Identifiers

DOI

10.1517/17425255.1.1.23

1 reference

28 June 2017

1 reference